<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68910">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02034240</url>
  </required_header>
  <id_info>
    <org_study_id>DNVK:1305 385</org_study_id>
    <nct_id>NCT02034240</nct_id>
  </id_info>
  <brief_title>Neutrophil Gelatinase Associated Lipocalin (NGAL) in Urine: Can This Prove to be a Biomarker for Acute Kidney Injury in Patients With Sepsis?</brief_title>
  <official_title>Secretion of Neutrophil Gelatinase Associated Lipocalin in Septic Patients and the Development of Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sygehus Lillebaelt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Anesthetics, Kolding Hospital, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sygehus Lillebaelt</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <authority>Denmark: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with severe infection and sepsis are in high risk of hypo perfusion and therefore
      organ affection. Temporary or permanent kidney failure is a common complication in these
      patients. Today's golden standard for kidney failure detection is creatinine levels rising
      and / or oliguria. The investigators hypothesize that an even more sensitive biomarker;
      neutrophil gelatinase associated lipocalin(NGAL) in urine can predict kidney injury before
      creatinine levels rise. In recent studies NGAL in urine seem to be a sensitive biomarker in
      these patient to predict kidney injury, but the time factor for sampling optimally is not
      known. In this pilot study the investigators sample the urine at admission within the first
      hour of hospitalization to investigate if NGAL can be used as a predictor in an emergency
      setting.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>N/A</study_design>
  <target_duration>5 Weeks</target_duration>
  <primary_outcome>
    <measure>Development of Acute Kidney Failure</measure>
    <time_frame>During hospitalization, anticipated approximately 5 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Levels of NGAL in patients with kidney failure compared to creatinine</measure>
    <time_frame>During hospitalization, anticipated approximately 5 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <condition>Acute Kidney Injury</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with no prior record of kidney failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe sepsis

          -  Septic shock

          -  Patients must not be able to give consent

        Exclusion Criteria:

          -  Underaged (18 years )

          -  known kidney injury

          -  Fully alert patients that can give consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jannie Bisgaard St√¶hr, PhD, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claes Falkenberg Elvander, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Kolding Sygehus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Srishamanthi Sriskandarajah, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kolding Sygehus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claes Falkenberg Elvander, M.D</last_name>
    <phone>0045 76362000</phone>
    <email>claes.falkenberg.elvander@rsyd.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faelles Akut Modtagelse, Kolding Sygehus</name>
      <address>
        <city>Kolding</city>
        <zip>6000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claes Falkenberg Elvander, M.D</last_name>
      <phone>004576362000</phone>
      <email>claes.falkenberg.elvander@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 1, 2014</lastchanged_date>
  <firstreceived_date>January 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sygehus Lillebaelt</investigator_affiliation>
    <investigator_full_name>Claes Falkenberg Elvander</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
